• HDAC Inhibitors Target NUT Function in NUT Carcinoma: Insigh

  2026-06-02

  Shiota et al. conducted a high-throughput chemical screen to uncover novel histone deacetylase (HDAC) inhibitors that repress NUT function in NUT carcinoma, a highly aggressive cancer driven by BRD4-NUT fusions. Their work demonstrates that diverse HDAC inhibitors disrupt BRD4-NUT-mediated oncogenic transcription and promote tumor cell differentiation, paving the way for new epigenetic therapeutic strategies in this rare malignancy.

• Advances in Plant Protein Secretion Protocols: Insights and

  2026-06-01

  The second edition of 'Plant Protein Secretion: Methods and Protocols' delivers rigorously validated, stepwise experimental methodologies for dissecting both conventional and unconventional protein secretion pathways in plant cells. The volume's comprehensive approach enables researchers to address plant-specific features of the secretory machinery, supporting advances in cell biology and applied plant science.

• Nicotine Signaling Accelerates CKD Progression in Smokers

  2026-06-01

  This review by Jain and Jaimes elucidates how nicotine, acting through renal nicotinic acetylcholine receptors, exacerbates chronic kidney disease (CKD) progression in smokers. By integrating clinical and experimental evidence, the study highlights oxidative stress and profibrotic pathways as key mechanisms, informing novel research directions for mitigating CKD risk among smokers.

• NHS-Biotin: Precision Biotinylation for Multimeric Protein W

  2026-05-31

  NHS-Biotin empowers researchers with robust, membrane-permeable biotinylation for streamlined detection, purification, and engineering of multimeric proteins. This article demystifies applied workflows and troubleshooting, translating cutting-edge findings into actionable protocols and optimization strategies.

• Tigecycline as a Glycylcycline Antibiotic: Applied Research

  2026-05-30

  Tigecycline unlocks robust experimental strategies for multidrug-resistant bacteria, bridging translational infection models and real-world resistance challenges. This article delivers validated workflows, troubleshooting tips, and protocol enhancements to maximize assay precision, especially in studying complex resistance gene dynamics.

• JHU-083 (SKU BA7770): Precision Glutaminase Inhibition in La

  2026-05-29

  This article provides evidence-based guidance for biomedical researchers and lab technicians utilizing JHU-083 (SKU BA7770) as a selective glutaminase inhibitor. It addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, drawing on recent literature and validated protocol parameters. JHU-083’s high purity, solubility, and targeted action support reproducible outcomes in glutaminase pathway and neurological disease research.

• 2'3'-cGAMP: Beyond Innate Immunity in Translational Research

  2026-05-29

  Explore how 2'3'-cGAMP (sodium salt) is redefining the boundaries of innate immunity research, revealing novel mechanisms in cell migration and providing strategic, actionable guidance for translational researchers navigating the cGAS-STING pathway, immunotherapy, and beyond.

• PDK4-IN-1 Hydrochloride: Precision PDK4 Inhibitor Workflows

  2026-05-28

  PDK4-IN-1 hydrochloride enables targeted mitochondrial energy metabolism modulation with nanomolar selectivity, streamlining metabolic research from in vitro cell studies to in vivo disease models. This article provides stepwise protocol guidance, troubleshooting insights, and highlights recent breakthroughs for researchers seeking reproducibility and translational impact.

• HyperScribe™ T7: Precision RNA Synthesis for Epitranscriptom

  2026-05-28

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit enables advanced, customizable RNA transcript engineering for epitranscriptomic research. Uncover new scientific insights and practical protocols for high-yield, modified RNA synthesis.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Degradatio

  2026-05-27

  Wang et al. (2025) identify the mitochondrial DNAJC co-chaperone TCAIM as a selective regulator of a-ketoglutarate dehydrogenase (OGDH) protein levels, operating through HSPA9 and LONP1 to modulate cellular metabolism. This work provides a new perspective on post-translational metabolic regulation, with implications for studying mitochondrial proteostasis and metabolic disorders.

• AM 281: Transforming CB1 Cannabinoid Receptor Antagonist Res

  2026-05-27

  AM 281 enables precise, reproducible dissection of CB1 cannabinoid receptor signaling in cognitive and traumatic brain injury models. This guide details workflow enhancements, troubleshooting, and actionable insights that set AM 281 apart for neuropharmacology research.

• Cy5 NHS ester(Et): Technical Guidance for Fluorescent Labeli

  2026-05-26

  Cy5 NHS ester(Et) offers a water-soluble, amine-reactive solution for fluorescent labeling of proteins and other biomolecules, especially in immunofluorescence, flow cytometry, and fluorescence microscopy workflows. It is unsuitable for ethanol-based protocols or long-term storage of dissolved solutions. Researchers seeking stable, high-purity tagging in aqueous or DMSO environments will benefit from its properties.

• Light-Inducible RNA-Releasing Proteins Enable Gene Switch Co

  2026-05-26

  The reference study introduces a rationally engineered light-inducible RNA-releasing protein (LIRP) that enables reversible, spatiotemporal translational control of gene therapies in vivo. This optogenetic advance offers new strategies for precise regulation of therapeutic transgene expression, particularly for chronic metabolic and retinal diseases requiring timely intervention.

• WY-14643 (Pirinixic Acid): Applied Protocols in Metabolic Re

  2026-05-25

  WY-14643 (Pirinixic Acid) is redefining metabolic and tumor microenvironment research through precision PPARα agonism. Discover optimized workflows, troubleshooting strategies, and translational use-cases that showcase its power in lipid regulation, inflammation control, and advanced metabolic models.

• Tamsulosin in Translational Urological Research Workflows

  2026-05-25

  Tamsulosin, a selective α₁A-adrenergic receptor antagonist, is redefining experimental and clinical urological research through robust, reproducible protocols for ureteral stone expulsion and postoperative urinary retention. This article details applied workflows, troubleshooting, and the latest evidence, empowering researchers and clinicians to maximize the translational potential of Tamsulosin from APExBIO.

450 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page